In conclusion, these results demonstrated that paeoniflorin ameliorates MPGN by inhibiting mesangial cell proliferation and inflammatory response through the PI3K/AKT/GSK-3β pathway. The gene discussed is AKT1; the disease is primary membranoproliferative glomerulonephritis.